Research graph
References from Bridging the Gap: A Patient-Navigation Decision Tool for ANCA-Associated Vasculitis. Local targets link to admitted publications; unresolved targets remain external evidence.
The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in Olmsted County, Minnesota: a twenty-year US population-based study
10.1002/art.40313 · 2017 · External reference
Diagnostic delays in vasculitis and factors associated with time to diagnosis
10.1186/s13023-021-01794-5 · 2021 · External reference
Unresolved reference
External reference
10.1002/art.37715
10.1002/art.37715 · 2013 · External reference
ANCA-associated vasculitis
10.1038/s41572-020-0204-y · 2020 · External reference
The delay and costs of diagnosing systemic vasculitis in a tertiary-level clinic
10.1007/s40744-020-00266-9 · 2021 · External reference
Outcomes and compliance with standards of care in anti-neutrophil cytoplasmic antibody-associated vasculitis: insights from a large multiregion audit
10.1093/rap/rky025 · 2018 · External reference
Health-related quality of life among adults with diverse rare disorders
10.1186/s13023-017-0730-1 · 2017 · External reference
Unresolved reference
2020 · External reference
The experiences of patients with rare diseases in Pennsylvania: a community-based study
10.1177/00333549251362711 · 2025 · External reference
Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients
10.1093/rap/rkac045 · 2022 · External reference
Unresolved reference
External reference
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis
10.1056/nejmoa0909169 · 2010 · External reference
Rituximab versus cyclophosphamide for ANCA-associated vasculitis
10.1056/nejmoa0909905 · 2010 · External reference
Unresolved reference
External reference
Unresolved reference
2026 · External reference
Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis
10.1056/nejmoa2311155 · 2024 · External reference
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term follow-up of the 383 patients enrolled in the French Vasculitis Study Group cohort
10.1002/art.37721 · 2013 · External reference
Healthcare access, satisfaction, and health-related quality of life among children and adults with rare diseases
10.1186/s13023-022-02343-4 · 2022 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Patient navigation in cancer treatment: a systematic review
10.1007/s11912-024-01514-9 · 2024 · External reference
History and principles of patient navigation
10.1002/cncr.26262 · 2011 · External reference
Unresolved reference
2024 · External reference
Unresolved reference
External reference
The diagnostic pathway and time to diagnosis in ANCA-associated vasculitis: a retrospective study at a tertiary rheumatology center
10.1007/s10067-026-08057-3 · 2026 · External reference
10.1002/art.37715
10.1002/art.37715 · ExternalCitation · doi-reference
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term follow-up of the 383 patients enrolled in the French Vasculitis Study Group cohort
10.1002/art.37721 · ExternalCitation · doi-reference
The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in Olmsted County, Minnesota: a twenty-year US population-based study
10.1002/art.40313 · ExternalCitation · doi-reference
History and principles of patient navigation
10.1002/cncr.26262 · ExternalCitation · doi-reference
The diagnostic pathway and time to diagnosis in ANCA-associated vasculitis: a retrospective study at a tertiary rheumatology center
10.1007/s10067-026-08057-3 · ExternalCitation · doi-reference
Patient navigation in cancer treatment: a systematic review
10.1007/s11912-024-01514-9 · ExternalCitation · doi-reference
The delay and costs of diagnosing systemic vasculitis in a tertiary-level clinic
10.1007/s40744-020-00266-9 · ExternalCitation · doi-reference
ANCA-associated vasculitis
10.1038/s41572-020-0204-y · ExternalCitation · doi-reference
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis
10.1056/nejmoa0909169 · ExternalCitation · doi-reference
Rituximab versus cyclophosphamide for ANCA-associated vasculitis
10.1056/nejmoa0909905 · ExternalCitation · doi-reference
Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis
10.1056/nejmoa2311155 · ExternalCitation · doi-reference
Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients
10.1093/rap/rkac045 · ExternalCitation · doi-reference
Outcomes and compliance with standards of care in anti-neutrophil cytoplasmic antibody-associated vasculitis: insights from a large multiregion audit
10.1093/rap/rky025 · ExternalCitation · doi-reference
The experiences of patients with rare diseases in Pennsylvania: a community-based study
10.1177/00333549251362711 · ExternalCitation · doi-reference
Health-related quality of life among adults with diverse rare disorders
10.1186/s13023-017-0730-1 · ExternalCitation · doi-reference
Diagnostic delays in vasculitis and factors associated with time to diagnosis
10.1186/s13023-021-01794-5 · ExternalCitation · doi-reference
Healthcare access, satisfaction, and health-related quality of life among children and adults with rare diseases
10.1186/s13023-022-02343-4 · ExternalCitation · doi-reference
